Interferon-γ and Human Megakaryopoiesis

References

• Weelock E.F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemaggutinin. Science 1965; 149: 310–311
   Web of Science ®Google Scholar
• Naylor S.L., Gray P.W., Lalley P.A. Mouse immune interferon (IFN-γ) gene is on chromosome 10. Somat. Cell Genet. 1984; 10: 531–534
   Google Scholar
• Gray P.W., Goeddel D.V. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 1983; 80: 5842–5846
   PubMed Web of Science ®Google Scholar
• Gray P.W., Leung D.W., Pennica D., Yervelton E., Najarian R., Simonsen C.C., Derynck R., Sherwood P.J., Wallace D.M., Berger S.L., Levinson A.D., Goeddel D.V. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982; 295: 503–508
   PubMed Web of Science ®Google Scholar
• Trent J.M., Olson S., Lawn R.M. Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc. Natl. Acad. Sci. USA 1982; 79: 7809–7813
   PubMed Web of Science ®Google Scholar
• Aguet M., Dembic Z., Merlin G. Molecular cloning and expression of the human interferon-γ receptor. Cell 1986; 55: 273–280
   Web of Science ®Google Scholar
• Mariano T.M., Kozak C.A., Langer J.A., Pestka S. The mouse immune interferon receptor gene is located on chromosome 10. J. Biol. Chem. 1987; 262: 5812–5814
   PubMed Web of Science ®Google Scholar
• Ucer U., Bartsch H., Scheurich P., Berkovic D., Ertel C., Pfizenmainer K. Quantitation and characterization of γ-interferon receptors on human tumor cells. Cancer Res. 1986; 46: 5339–5343
   PubMed Web of Science ®Google Scholar
• Rubinstein M., Novick D., Fischer D.G. The human interferon-γ receptor system. Immunol. Rev. 1987; 97: 29–50
   PubMed Web of Science ®Google Scholar
• Blalock J.E., Georgiades J.A., Langford M.P., Johnson H.M. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell. Immunol. 1980; 49: 390–394
   PubMed Web of Science ®Google Scholar
• Tyring S., Klimpel G.R., Fleishmann W.R., Baron S. Direct cytolysis by partially-purified preparations of immune interferon. Int. J. Cancer 1980; 30: 59–64
   Web of Science ®Google Scholar
• Heron I., Hokland M., Berg K. Enhanced expression of β2-microglobulin and HLA antigen on human lymphoid cells by interferon. Proc. Natl. Acad. Sci. USA 1978; 75: 6215–6219
   PubMed Web of Science ®Google Scholar
• Fridman W.H., Gresser I., Bandu M.T., Aguet M., Neauport-Sautes C. Interferon enhances the expression of Fey receptors. J. Immunol. 1980; 124: 2436–2441
   PubMed Web of Science ®Google Scholar
• Gajewski T.F., Goldwasser E., Fitsh F.W. Antiproliferative effect of IFN-γ in murine regulation. I. IFN-γ inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. J. Immunol. 1988; 141: 2635–2642
   PubMed Web of Science ®Google Scholar
• Koike K., Ma F., Shiohara M., Kubo T., Takagi M., Amano Y., Nakahata T., Komiyama A. Interferon-gamma inhibits proliferation, but not commitment, of murine granulocyte-macrophage progenitors. J. Cell. Physiol. 1990; 153: 528–533
   Web of Science ®Google Scholar
• Shiohara M., Koike K., Nakahata T. Synergism of IFN-γ and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood 1993; 81: 1435–1441
   PubMed Web of Science ®Google Scholar
• Muraoka K., Tsuji K., Yoshida M., Ebihara Y., Yamada K., Sui X., Tanaka R., Nakahata T. Thrombopoietin independent effect of interferon-γ on the proliferation of human megakaryocyte progenitors. Br. J. Haematol. 1997; 98: 265–273
   PubMed Web of Science ®Google Scholar
• Broxmeyer H.E., Lu L., Feit C., Juliano L., Rubin B.Y. Comparison analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 1983; 131: 1300–1305
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Cazzola M., Ganser A., Bergamschi G., Pedrazzoli P., Hoelzer D., Ascari E. Synergistic antiproliferative effect of recombinant interferon-γ with recombinant interferon-α on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM). Blood 1988; 72: 1293–1299
   PubMed Web of Science ®Google Scholar
• Kawano Y., Takaue Y., Hirao A., Abe T., Saito S., Matsunaga K., Watanabe T., Hirose M., Ninomiya T., Kuroda Y., Yokobayashi A., Asano S. Synergistic effect of recombinant interferon-γ and interleukin-3 on the growth of immature human hematopoietic progenitors. Blood 1991; 77: 2118–2121
   PubMed Web of Science ®Google Scholar
• Caux C., Moreau I., Saeland S., Banchereau J. Interferon-γ enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood 1992; 79: 2628–2635
   PubMed Web of Science ®Google Scholar
• Brugger W., Mocklin W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, interferon-γ and erythropoietin. Blood 1993; 81: 2579–2584
   PubMed Web of Science ®Google Scholar
• Monté D., Wietzerbin J., Pancre V., Merlin G., Greenberg S.M., Kusnierz J.P., Capron A., Auriault C. Identification and characterization of a functional receptor for interferon-γ on a megakaryocytic cell line. Blood 1991; 78: 2062–2069
   PubMed Web of Science ®Google Scholar
• Murohashi I., Hoang T. Interferon-γ enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1991; 78: 1085–1095
   PubMed Web of Science ®Google Scholar
• Dukes P.P., Izadi P., Ortega J.A., Gomperts E. Inhibitory effect of interferon on mouse megakaryocytic progenitor cells in culture. Exp. Hematol. 1980; 8: 1048–1053
   PubMed Web of Science ®Google Scholar
• Ganser A., Carlo-Stella C., Greher J., Volkers B., Hoelzer D. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood 1987; 70: 1173–1179
   PubMed Web of Science ®Google Scholar
• Griffin C.G., Grant B.W. Effects of recombinant interferons on human megakaryocyte growth. Exp. Hematol. 1990; 18: 1013–1018
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V.C, Lin N., Jorgensen M.J., McCarty J., Fox N., Zucker-Franklin D., Lofton-Day C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc. Natl. Acad. Sci. USA 1995; 92: 3234–3238
   PubMed Web of Science ®Google Scholar
• Molinas F.C., Wietzerbin J., Falcoff E. Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-γ. J. Immunol. 1987; 138: 802–806
   PubMed Web of Science ®Google Scholar
• Debili N., Masse J.M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effect of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 1993; 82: 84–95
   PubMed Web of Science ®Google Scholar
• Imai T., Koike K., Kubo T., Kikuchi T., Amano Y., Takagi M., Okumura N., Nakahata T. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood 1991; 78: 1969–1974
   PubMed Web of Science ®Google Scholar
• Burstein S.A., Mei R.L., Henthorn J., Friese P., Turner K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J. Cell. Physiol. 1992; 153: 305–312
   PubMed Web of Science ®Google Scholar
• Imai T., Nakahata T. Stem cell factor promotes proliferation of human primitive megakaryocytic progenitors, but not megakaryocytic maturation. Int. J. HematoL 1994; 59: 91–98
   PubMed Web of Science ®Google Scholar
• Tanaka R., Koike K., Imai T., Shiohara M., Kubo T., Amano Y., Komiyama A., Nakahata T. Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture. Blood 1992; 80: 1743–1749
   PubMed Web of Science ®Google Scholar
• Debili N., Wendling F., Katz A., Guichard J., Breton-Gorius J., Hunt P., Vainchenker W. The Mpl-lig-and or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differen-tiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516–2525
   PubMed Web of Science ®Google Scholar
• Nichol J.L., Hokom M.M., Hornkohl A., Sheridan W.P., Ohashi H., Kato T., Li Y.S., Bartley T.D., Choi E., Bogenberger J., Skrine J.D., Knudten A., Chen J., Trail G., Sleeman L., Cole S., Grampp G., Hunt P. Megakaryocyte growth and development factor. Analysis of in vitro effects on human megakaryocytopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J. Clin. Invest. 1995; 95: 2973–2978
   PubMed Web of Science ®Google Scholar
• Key L.L., Rodriguiz R.M., Willi S.M., Wright N.M., Hatcher H.C., Eyre D.R., Cure J.K., Griffin P.P., Ries W.L. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N. Eng. J. Med. 1995; 332: 1594–1599
   PubMed Web of Science ®Google Scholar
• The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Eng. J. Med. 1991; 324: 509–516
   PubMed Web of Science ®Google Scholar
• J Zoumbos N.C., Gascon P., Djeu J.Y., Young N.S. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc. Natl. Acad. Sci. USA 1985; 82: 188–192
   PubMed Web of Science ®Google Scholar
• Torok-Storb B., Johnson G.G., Bowden R., Storb R. Gamma-interferon in aplastic anemia: Inability to detect significant levels in sera or demonstrate hematopoietic suppressing activity. Blood 1987; 69: 629–633
   PubMed Web of Science ®Google Scholar
• Nakao S., Yamaguchi M., Shiobara S., Yokoi T., Miyawaki T., Taniguchi T., Matsuda T. Interferon-γ gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 1992; 79: 2532–2535
   PubMed Web of Science ®Google Scholar
• Imashuku S., Ikushima S., Esumi N., Todo S., Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophago-cytic syndromes. Leukemia & Lymphoma 1991; 3: 287–292
   PubMed Web of Science ®Google Scholar
• Takahashi M., Motoji T., Oshimi K., Mizoguchi H. Effect of recombinant interferons on colony formation of blast progenitors in acute myeloblastic leukemia. Exp. HematoL 1987; 15: 946–951
   PubMed Web of Science ®Google Scholar
• Beran M., McCredie K.B., Keating M.J., Gutterman J.U. Antileukemic effect of recombinant tumor necrosis factor α and γ interferon. Blood 1988; 72: 728–738
   PubMed Web of Science ®Google Scholar